PDS Biotechnology Corporation (PDSB) Total Assets by Year
PDS Biotechnology Corporation closed fiscal year 2025 with $30.5M in total assets, $21.2M in total liabilities and $9.3M in shareholder equity. This represents a decrease of 32.8% from the prior fiscal year. The table below carries 13 fiscal years, from 2013 to 2025, and the quarters PDS Biotechnology Corporation has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
PDSB Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY25DEF 14A | FY24DEF 14A | FY23DEF 14A | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $30.5M-32.8% | $45.4M-23.6% | $59.4M-22.9% | $77.0M+14.6% | $67.2M+117.5% | $30.9M+113.2% | $14.5M+8713.0% | $164K-99.8% | $92.6M-16.5% | $110.9M-17.3% | $134.1M+696.0% | $16.8M | N/A |
| Total Liabilities | $21.2M-19.4% | $26.4M-20.8% | $33.3M+0.8% | $33.0M+727.7% | $4.0M+6.0% | $3.8M+34.6% | $2.8M+25.2% | $2.2M-97.6% | $93.2M+330.9% | $21.6M+86.3% | $11.6M-74.0% | $44.7M | N/A |
| Total Equity | $9.3M-51.3% | $19.0M-27.3% | $26.1M-40.6% | $44.0M-30.4% | $63.2M+133.0% | $27.1M+131.9% | $11.7M+666.1% | -$2.1M-239.0% | -$610K-100.7% | $89.3M-27.1% | $122.5M+540.0% | -$27.8M-81.3% | -$15.3M |
PDSB Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-K | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-K | Q2'2410-K | Q1'2410-K | Q4'2310-Q | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $8.8M-78.2% | $24.7M-47.6% | $30.5M-32.8% | $34.7M-33.8% | $40.5M-33.1% | $47.0M-31.8% | $45.4M-23.6% | $52.5M-8.3% | $60.5M-5.1% | $69.0M+0.8% | $59.4M-22.9% | $57.2M-23.6% |
| Total Liabilities | $12.4M-49.5% | $20.8M-15.8% | $21.2M-19.4% | $25.3M-17.1% | $24.5M-17.1% | $24.7M-22.5% | $26.4M-20.8% | $30.4M-6.9% | $29.6M-5.5% | $31.8M+16.0% | $33.3M+0.8% | $32.7M+17.5% |
| Total Equity | -$3.6M-122.4% | $3.9M-82.6% | $9.3M-51.3% | $9.5M-57.0% | $16.0M-48.4% | $22.4M-39.9% | $19.0M-27.3% | $22.0M-10.1% | $30.9M-4.7% | $37.2M-9.3% | $26.1M-40.6% | $24.5M-48.0% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More PDS Biotechnology Corporation financials
Frequently Asked Questions
What was PDS Biotechnology Corporation's total assets in fiscal year 2025?
PDS Biotechnology Corporation closed fiscal year 2025 with $30.5M in total assets, $21.2M in total liabilities and $9.3M in shareholder equity.
How fast is PDS Biotechnology Corporation's total assets growing?
PDS Biotechnology Corporation (PDSB) total assets fell by 32.8% year over year, from $45.4M to $30.5M in fiscal year 2025.
What was PDS Biotechnology Corporation's total assets in the most recent quarter?
PDS Biotechnology Corporation (PDSB) reported $8.8M in total assets in Q2 2026. This represents a decrease of 78.2% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what PDS Biotechnology Corporation (PDSB) reported on that line in every period on record.